A 16-year-old patient died after treatment with Elevidys (delandistrogene moxeparvovec), Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy (DMD). The patient suffered acute liver failure several months after receiving the therapy in December. Liver injury is a known risk with Elevidys and other gene therapies that use adeno-associated viral (AAV) vectors. However, this is the […]
News
Life Science News
Pharma News
Biotech News
Medical Device News
Healthcare News
Food News
Videos
Blogs
Life Sciences Quizzes & Polls